FI924817A0 - Behandling av stoerd funktion av erektion - Google Patents

Behandling av stoerd funktion av erektion

Info

Publication number
FI924817A0
FI924817A0 FI924817A FI924817A FI924817A0 FI 924817 A0 FI924817 A0 FI 924817A0 FI 924817 A FI924817 A FI 924817A FI 924817 A FI924817 A FI 924817A FI 924817 A0 FI924817 A0 FI 924817A0
Authority
FI
Finland
Prior art keywords
agent
agents include
agents
stoerd
erektion
Prior art date
Application number
FI924817A
Other languages
English (en)
Other versions
FI924817A (fi
FI104946B (fi
Inventor
Virgil A Place
Robert M Gale
Randall G Berggren
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI924817A publication Critical patent/FI924817A/fi
Publication of FI924817A0 publication Critical patent/FI924817A0/fi
Application granted granted Critical
Publication of FI104946B publication Critical patent/FI104946B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41Devices for promoting penis erection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/16Male reproductive, genital organs
    • A61M2210/167Penis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nursing (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Steroid Compounds (AREA)
FI924817A 1990-04-25 1992-10-23 Laite aktiivisen aineen antamiseksi virtsaputkeen FI104946B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51439790A 1990-04-25 1990-04-25
US51439790 1990-04-25
PCT/US1991/002758 WO1991016021A1 (en) 1990-04-25 1991-04-22 Treatment of erectile dysfunction
US9102758 1991-04-22

Publications (3)

Publication Number Publication Date
FI924817A FI924817A (fi) 1992-10-23
FI924817A0 true FI924817A0 (fi) 1992-10-23
FI104946B FI104946B (fi) 2000-05-15

Family

ID=24046960

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924817A FI104946B (fi) 1990-04-25 1992-10-23 Laite aktiivisen aineen antamiseksi virtsaputkeen

Country Status (16)

Country Link
EP (1) EP0526566B1 (fi)
JP (1) JP3477197B2 (fi)
KR (1) KR0169950B1 (fi)
AT (1) ATE173603T1 (fi)
AU (1) AU655420B2 (fi)
CA (2) CA2352552C (fi)
DE (1) DE69130529T2 (fi)
DK (1) DK0526566T3 (fi)
ES (1) ES2124225T3 (fi)
FI (1) FI104946B (fi)
IE (1) IE81089B1 (fi)
NO (1) NO300083B1 (fi)
NZ (2) NZ237899A (fi)
PT (1) PT97441B (fi)
WO (1) WO1991016021A1 (fi)
ZA (1) ZA912984B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
NZ305560A (en) * 1995-03-14 1998-11-25 Vivus Inc Method for preventing erectile dysfunction by administering vasoactive agent, particularly a prostaglandin, kit therefor
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5855548A (en) * 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
AU1827299A (en) * 1997-12-18 1999-07-05 Nathan Earl Scott Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
AU1414200A (en) * 1998-12-02 2000-06-19 Mochida Pharmaceutical Co., Ltd. Preparations for intraurethral administration
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
NZ579170A (en) 2007-02-12 2012-05-25 Dmi Biosciences Inc Reducing side effects of tramadol
SG174079A1 (en) 2007-02-12 2011-09-29 Dmi Biosciences Inc Treatment of comorbid premature ejaculation and erectile dysfunction
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
AU2016205336A1 (en) 2015-01-06 2017-08-03 Venturis Therapeutics, Inc. Angiogenic treatment of ischemic heart disease
WO2016133848A2 (en) * 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10653549B2 (en) * 2017-07-18 2020-05-19 Carl W. Lange, IV Topical medication method for erectile dysfunction
BR102019016950A2 (pt) * 2019-08-15 2021-02-23 Inst De Pesquisa Ensino Ciencia E Tecnologia Aplicada Inst Galzu forma de dosagem intrauretral de medicamento; e dispositivo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1897423A (en) * 1928-10-30 1933-02-14 Ferri Filiberto Device for preventing gonorrhea infection
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
AU7856391A (en) 1991-11-11
CA2040914A1 (en) 1991-10-26
FI924817A (fi) 1992-10-23
CA2352552C (en) 2008-12-02
JPH05506800A (ja) 1993-10-07
ZA912984B (en) 1992-01-29
CA2352552A1 (en) 1991-10-26
IE911330A1 (en) 1991-11-06
DE69130529T2 (de) 1999-06-02
PT97441B (pt) 1998-08-31
IE81089B1 (en) 2000-03-08
AU655420B2 (en) 1994-12-22
EP0526566B1 (en) 1998-11-25
KR930700048A (ko) 1993-03-13
NO924032D0 (no) 1992-10-19
KR0169950B1 (ko) 1999-01-15
NO924032L (no) 1992-10-26
NZ270871A (en) 1999-05-28
WO1991016021A1 (en) 1991-10-31
PT97441A (pt) 1992-05-29
ATE173603T1 (de) 1998-12-15
NO300083B1 (no) 1997-04-07
FI104946B (fi) 2000-05-15
JP3477197B2 (ja) 2003-12-10
NZ237899A (en) 1997-03-24
DE69130529D1 (de) 1999-01-07
CA2040914C (en) 2001-12-04
ES2124225T3 (es) 1999-02-01
DK0526566T3 (da) 1999-08-09
EP0526566A1 (en) 1993-02-10

Similar Documents

Publication Publication Date Title
FI924817A (fi) Behandling av stoerd funktion av erektion
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
PE20010924A1 (es) Compuestos inhibidores de fosfodiesterasa utiles para el tratamiento de la disfuncion sexual femenina
DK629189A (da) Indretning til brug ved urinal inkontinens
JP2003505345A5 (fi)
SE8601246D0 (sv) Utvendig kateter for men och paforingskrage for denna
DE69215612D1 (de) Verzögerte Freigabe-Matrix für Arzneimittel
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
ATE120648T1 (de) Schmerzstillendes und entzündungshemmendes pflaster.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
ES2120433T3 (es) Pesario retirable.
MY106528A (en) Method of treating impotence.
WO1999030718A3 (en) PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
EP0459377A3 (en) Use of e1 prostaglandin to cure male erectile inpotence
ZA969351B (en) Organic compositions
BE894860A (fr) Therapeutique adjuvante par agent progestatif
DE69943219D1 (de) Antikörper verwiesene enzymprodrugtherapie mit glukuronidase
Zufferey Risques vrais et faux de la contraception locale: spermicides, diaphragme
SE8904384D0 (sv) Pharmaceutical composition
BR9609868A (pt) Conjugado sintético de uma proteína e uma pluralidade de epítopos para uso em medicina processos para evitar a rejeição de um xenoenxerto ou pelo menos reduzir a extensão ou taxa de rejeição para tratar uma doença e sangue removido de um doador de sangue aparelho sangue composição farmaceuticamente aceitável e uso de um conjugado
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
IT1238674B (it) Formulazione combinata di cimetidina-pirenzepina per il trattamento di ulcere ed erosioni peptiche
UA41462C2 (uk) Спосіб лікування гострого пієлонефриту
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: VIVUS, INC.